These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 767252)

  • 1. In vitro responses of primed rabbit lymph node cells to myoglobin and its synthetic antigenic peptides: production of macrophage inhibitory factor and antibody to myoglobin.
    Stavitsky AB; Atassi MZ; Gooch GT; Pelley RP; Harold WW
    Immunochemistry; 1975 Dec; 12(12):959-65. PubMed ID: 767252
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro responses of myoglobin-primed lymph node cells to myoglobin and myoglobin synthetic antigenic peptides.
    Stavitsky AB; Atassi MZ; Gooch GT; Manderino GL; Harold WW; Pelley RP
    Adv Exp Med Biol; 1978; 98():199-219. PubMed ID: 82384
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthetic myoglobin peptides inhibit spontaneous anamnestic antibody responses by myoglobin-primed rabbit lymph node cells.
    Stavitsky AB; Atassi MZ; Gooch GT; Harold WW
    Cell Immunol; 1979 Jun; 45(1):195-8. PubMed ID: 455484
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of macrophage in antibody formation--significance of lymph node cells contacting the antigen-ingesting macrophage.
    Yokomuro K; Mabuchi A; Kimura Y
    J Reticuloendothel Soc; 1972 Jul; 12(1):53-61. PubMed ID: 4561350
    [No Abstract]   [Full Text] [Related]  

  • 5. Short-term direct, and macrophage stimulated, bactericidal properties of antigen-activated lymph node cell culture fluids.
    Parish WE; Wardle GR; Cowan SI
    Scand J Respir Dis Suppl; 1974; 89():15-28. PubMed ID: 4137926
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic control of the immune response to myoglobin. V. Antibody production in vitro is macrophage and T cell-dependent and is under control of two determinant-specific Ir genes.
    Kohno Y; Berzofsky JA
    J Immunol; 1982 Jun; 128(6):2458-64. PubMed ID: 6176636
    [No Abstract]   [Full Text] [Related]  

  • 7. Variation of macrophage migration by a factor from regional lymph node cells of breast cancer patients.
    Fisher B; Golinger RC; Kelly M; Ruth D
    Cancer; 1978 Nov; 42(5):2097-100. PubMed ID: 363251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of immunoglobulin receptors on lymphocytes in production of MIF in guinea pigs.
    Gościcka T
    Cell Immunol; 1974 Aug; 13(2):207-15. PubMed ID: 4141646
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemolytic plaque inhibition by synthetic antigenic peptides of sperm whale myoglobin.
    Allen EM; Abramoff P; Fink JN; Calvanico NJ
    Immunol Invest; 1985 Aug; 14(4):329-39. PubMed ID: 2415451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of T-lymphocyte lines and clones with specificities to preselected protein sites by in vitro passage with free synthetic peptides: demonstration with myoglobin sites.
    Yoshioka M; Bixler GS; Atassi MZ
    Mol Immunol; 1983 Oct; 20(10):1133-7. PubMed ID: 6609306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Induction of antibody synthesis in lymph node organ cultures].
    Luriia EA; Nikolaeva AI; Gurvich AE; Fridenshteĭn AIa
    Biull Eksp Biol Med; 1967 Jul; 63(7):73-6. PubMed ID: 5630329
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on lymphokines: the production of antibody to guinea pig lymphotoxin and its use to distinguish lymphotoxin from migration inhibitory factor and mitogenic factor.
    Gately MK; Gately CL; Henney CS; Mayer MM
    J Immunol; 1975 Sep; 115(3):817-26. PubMed ID: 1097529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of contact sensitivity by IgG1 antihapten antibody. IgG1 antihapten antibody suppresses migration inhibitory factor production by lymph node cells.
    Katayama I; Nishioka K
    Int Arch Allergy Appl Immunol; 1983; 70(2):178-84. PubMed ID: 6337109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of macrophages to defective delayed-type hypersensitivity in B6/lpr mice.
    Okuyama H; Yamamoto K; Matsunaga T; Kobayashi S; Hashimoto Y
    Clin Exp Immunol; 1986 Dec; 66(3):599-605. PubMed ID: 3552337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two large immunogenic and antigenic myoglobin peptides and the effects of cyclisation.
    Dorow DS; Shi PT; Carbone FR; Minasian E; Todd PE; Leach SJ
    Mol Immunol; 1985 Nov; 22(11):1255-64. PubMed ID: 4079944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different cellular site for the production of murine macrophage migration inhibitory factor and immune interferon (Type II).
    Neumann C; Sorg C
    Adv Exp Med Biol; 1979; 114():479-83. PubMed ID: 380299
    [No Abstract]   [Full Text] [Related]  

  • 17. Cell-mediated immunity after bacterial infection of the lower respiratory tract.
    Cantey JR; Hand WL
    J Clin Invest; 1974 Nov; 54(5):1125-34. PubMed ID: 4153573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-lymphocyte recognition of sperm-whale myoglobin. Responses of T-cells from mouse strains primed with synthetic peptide carrying antigenic site 5 and relation to antigen presentation.
    Young CR; Atassi MZ
    J Immunogenet; 1983 Apr; 10(2):151-60. PubMed ID: 6189918
    [No Abstract]   [Full Text] [Related]  

  • 19. Interaction between 'sensitized lymphocytes' and antigen in vitro. 3. Release of soluble mediators by particulate antigen.
    Pick E; Krejci J; Turk JL
    Immunology; 1972 Jan; 22(1):25-37. PubMed ID: 4259119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antibody response to myoglobin--I. Systematic synthesis of myoglobin peptides reveals location and substructure of species-dependent continuous antigenic determinants.
    Rodda SJ; Geysen HM; Mason TJ; Schoofs PG
    Mol Immunol; 1986 Jun; 23(6):603-10. PubMed ID: 2427938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.